These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38328)

  • 21. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
    Lawson JH; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
    Iur'ev EG; Iur'eva TI
    Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K; Oshima T; Kumakura S; Hashimoto K
    Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
    [No Abstract]   [Full Text] [Related]  

  • 26. [Search for new drugs with antiarrhythmic properties among derivatives of adamant-2-ylamides of alkylamidocarbonic acids].
    Turilova AI; Avdiutina NI; Piatin BM; Grushevskaia LN; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2013; 76(8):20-3. PubMed ID: 24228484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs.
    Kaschube M; Brasch H
    Cardiovasc Res; 1991 Mar; 25(3):230-4. PubMed ID: 2029712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic properties of a new quinidine analog, cupreidine (6'-hydroxycinchonine).
    Nwangwu PU; Holcslaw TL; Stohs SJ; Rosenberg H; Small LD; Modrak JB
    J Cardiovasc Pharmacol; 1982; 4(1):124-8. PubMed ID: 6176787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New method for producing atrial arrhythmia by aconitine (cup method) and evaluation of antifibrillatory activity of ajmaline, propranolol, procainamide and quinidine].
    Nakayama K; Kumakura S
    Nihon Yakurigaku Zasshi; 1968 May; 64(3):385-92. PubMed ID: 5749309
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of certain lupanin alkaloids on post-aconitine arrhythmia of the isolated heart].
    Czarnecka E; Kolińska-Marzec A; Szadowska A
    Acta Pol Pharm; 1967; 24(5):545-8. PubMed ID: 6062764
    [No Abstract]   [Full Text] [Related]  

  • 33. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
    Singh BN
    Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 35. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy].
    Pastelin G; Cuevas B; Alvarado JL; Méndez R
    Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584
    [No Abstract]   [Full Text] [Related]  

  • 36. Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels.
    Zhao Z; Yin Y; Wu H; Jiang M; Lou J; Bai G; Luo G
    Cell Physiol Biochem; 2013; 32(5):1342-53. PubMed ID: 24280730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antiarrhythmic activity of the polymeric forms of quinidine, trimecaine, etatsizin, propranolol and verapamil].
    Sidorenko GI; Gurin AV; Koliadko MG; Iurkshtovich TL; Nedorezov VL
    Eksp Klin Farmakol; 1993; 56(3):27-30. PubMed ID: 8219985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The anti-arrhythmia action of low-molecular polyvinylpyrrolidone in experimental arrhythmias].
    Mirzaev NA
    Eksp Klin Farmakol; 1993; 56(2):24-6. PubMed ID: 8348030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
    Buxton AE; Josephson ME
    Circulation; 1986 Feb; 73(2 Pt 2):II67-72. PubMed ID: 3943175
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.